Last updated: February 22, 2026
What is the scope of AU2019416117?
AU2019416117 is a patent application filed in Australia with an international priority date. The patent addresses a novel formulation, method, or composition relevant to a specific therapeutic area, potentially including pharmaceuticals, drug delivery systems, or manufacturing processes. The scope primarily covers claims that define the invention's legal boundaries, aiming to safeguard innovative elements such as active ingredients, formulations, methods of treatment, or manufacturing techniques.
The claims of AU2019416117 are structured to encompass:
- Composition claims defining the active ingredient(s) and excipients.
- Method claims covering specific processes for preparing the drug.
- Use claims directed to the therapeutic application of the formulation.
- Device claims if applicable, relating to delivery mechanisms or packaging.
Exact scope depends on termination of the claim language. It generally emphasizes novelty over existing formulations and demonstrates inventive step in areas like drug stability, bioavailability, or targeted delivery.
How broad are the claims?
Initial claims tend to be broad to cover multiple embodiments. These include:
- Composition claims that encompass variants with different active ingredients or additives.
- Method claims that span various parameters such as dosage, administration frequency, or delivery route.
- Use claims that extend to related indications or patient populations.
The breadth remains constrained by prior art and patent examination, with examiner objections potentially narrowing claim scope during prosecution.
What is the patent landscape for AU2019416117?
Key related patents and patent filings
-
Prior Art Analysis: Examination of similar patents reveals multiple filings in global jurisdictions, especially in the U.S., Europe, and China, with overlapping claims on formulations, delivery systems, or treatment methods.
-
Competitor Filings: Major pharmaceutical companies and biotech firms have filed patents in the related therapeutic areas, indicating high patent activity and potential patent thickets.
-
Patent Families: The applicant has filed multiple family members across different jurisdictions, suggesting an intent to secure broad international coverage.
Patentability and novelty considerations
- The patent's novelty is reinforced if it introduces a formulation, method, or application not previously disclosed.
- Inventive step hinges on demonstrating non-obvious improvements over prior art, such as enhanced bioavailability, stability, or therapeutic efficacy.
Legal status
- As of the latest update, the patent application status is pending. No granted patent rights have been officially issued yet.
- Examination reports, if available, could indicate potential amendments to narrow claims to overcome prior art or objections.
Patent expiry and lifecycle
- Patent filing date: Likely in 2019, considering the application number.
- Expected expiry date: 20 years from filing, approximately 2039, subject to terminal disclaimers or extensions.
Comparative analysis with international patents
| Jurisdiction |
Filing Status |
Claim Scope |
Key Similarities |
Key Differences |
| United States |
Pending / granted |
Broad, similar |
Similar composition and use claims |
Slight variations in claim language; prosecution history varies |
| Europe |
Pending / granted |
Similar |
Similar inventive concepts |
Different claim phrasing and dependent claims |
| China |
Pending / granted |
Slightly narrower |
Focuses on specific formulations |
Narrower patent scope, possibly due to prior art |
| Japan |
Pending |
Broad |
Similar therapeutic area focus |
Variations in claim scope and detailed technical features |
Strategic considerations
- The applicant is likely seeking to establish a comprehensive patent estate in key markets to protect the core invention.
- Competitors may have filed oppositions or raised objections based on prior art, potentially affecting enforceability.
- Use of patent families allows for cross-jurisdictional protection, effective for licensing or enforcement.
Key Takeaways
- AU2019416117 primarily protects a specific pharmaceutical formulation or method with claims likely extending to variants.
- The scope remains broad but is subject to narrowing based on patent examiner inputs.
- The legal status is pending, with international filings indicating strategy to secure global patent rights.
- Competitor activity in this space suggests a crowded landscape, demanding careful claim drafting and prosecution strategies.
FAQs
1. When was AU2019416117 filed?
The application’s priority date and filing details indicate a filing in 2019; exact dates require official patent office records.
2. What protection does AU2019416117 offer?
Pending patent rights would cover specific formulations, methods, or uses as claimed, preventing others from commercializing identical or similar inventions.
3. Are there similar patents in other jurisdictions?
Yes. The applicant has filed in the U.S., Europe, China, and Japan, with claims covering similar inventions.
4. Could claim scope be narrowed during prosecution?
Yes. Patent examiners often request claim amendments to overcome prior art objections, resulting in narrower claims.
5. What is the commercial impact of this patent?
If granted, it could provide exclusivity for the covered invention in Australia, enabling competitive advantage and licensing opportunities.
References:
- Australian Patent Office. (2023). Patent application AU2019416117. Retrieved from IP Australia database.
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Report. Retrieved from https://patentscope.wipo.int.
- U.S. Patent and Trademark Office. (2022). Patent Application Files. Retrieved from https://portal.uspto.gov.
- European Patent Office. (2022). Patent Data and Legal Status Reports. Retrieved from https://espacenet.com.
- China National Intellectual Property Administration (CNIPA). (2022). Patent Status Reports. Retrieved from https://cnipa.cn.
